Stop Astrazeneca to under 60, but what to do with the Johnson & Johnson vaccine?

Stop Astrazeneca to under 60, but what to do with the Johnson & Johnson vaccine?

Don't store avocado like this: it's dangerous

After the stop announced yesterday to the AstraZeneca vaccine for the under 60s, the circular from the Ministry of Health arrives, with the opinion of the CTS attached. This vaccine will only be given to people over 60. But what do we know about the Johnson & Johnson vaccine?





“Vaxzevria vaccine is only given to people 60 years of age or older (full course). For people who have received the first dose of this vaccine and are under 60 years of age, the course should be completed with a second dose of mRNA vaccine (Comirnaty or Moderna), to be given 8-12 years apart. weeks from the first dose ”, reads the circular.

The document 'on Cts Vaccines Opinion Update,' signed by the Director General of Health Prevention, Gianni Rezza, and based on the opinion of the Technical Scientific Committee, nothing currently says about the Johnson & Johnson vaccine, which just like Astrazeneca, is a viral success, albeit with the difference of being single-dose.

How should someone who has booked for the Janssen vaccination and is under 60 behave?

For now there are no specific indications in this regard and more precise communications will certainly arrive in the coming days.

Locatelli explained that the frequency of serious adverse events is lower and at this time no decision has been made on the matter, remembering that J&J uses a human adenovirus, and not chimpanzees like Astrazeneca.

“We still have a significantly smaller number of subjects in the country, we are around 1 million 100 thousand doses. I believe that the task of the CTS is to provide all these elements to the decision that belongs to the policy, underlining the known information and the areas of uncertainty ”, explains the expert.

Now, in any case, each Region will have to adapt its vaccination campaign. And it will be necessary to understand if the reservations of the under 60s of Astrazeneca, but also of J&J, will be maintained (but the inoculated vaccines replaced). Or if you will have to book again.


In any case, the message is clear: the CTS strongly recommended allocate mRna, Pfizer and Moderna vaccines to younger people.


Anyone under 60 who has to get the Astrazeneca recall will be inoculated with Pfizer or Moderna. 

 

add a comment of Stop Astrazeneca to under 60, but what to do with the Johnson & Johnson vaccine?
Comment sent successfully! We will review it in the next few hours.